These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16827102)

  • 1. Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration.
    Zang XP; Palwai NR; Lerner MR; Brackett DJ; Pento JT; Harrison RG
    Anticancer Res; 2006; 26(3A):1745-51. PubMed ID: 16827102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of L-methioninase targeted to the urokinase receptor on the proliferation and motility of lung and prostate cancer cells.
    Palwai NR; Zang XP; Harrison RG; Pento JT
    Anticancer Res; 2007; 27(5A):3435-9. PubMed ID: 17970092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation.
    Peron K; Jones TN; Gauthier SA; Nguyen TN; Zang XP; Barriere M; Prévéraud D; Soliman CE; Harrison RG; Pento JT
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):270-6. PubMed ID: 12827296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study of anti-metastasis effect of urokinase amino-terminal fragment gene on human breast cancer cells].
    Zhu F; Xing G; He F
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):115-7. PubMed ID: 11783013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer efficacy of methioninase in vivo.
    Tan Y; Xu M; Guo H; Sun X; Kubota T; Hoffman RM
    Anticancer Res; 1996; 16(6C):3931-6. PubMed ID: 9042315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
    Belosay A; Brodie AM; Njar VC
    Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.
    Todhunter DA; Hall WA; Rustamzadeh E; Shu Y; Doumbia SO; Vallera DA
    Protein Eng Des Sel; 2004 Feb; 17(2):157-64. PubMed ID: 15047912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment.
    Miki K; Al-Refaie W; Xu M; Jiang P; Tan Y; Bouvet M; Zhao M; Gupta A; Chishima T; Shimada H; Makuuchi M; Moossa AR; Hoffman RM
    Cancer Res; 2000 May; 60(10):2696-702. PubMed ID: 10825143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of serum methionine by methioninase in mice.
    Lishko VK; Lishko OV; Hoffman RM
    Anticancer Res; 1993; 13(5A):1465-8. PubMed ID: 8239522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective growth inhibition of cancer cells by L-methioninase-containing fusion protein targeted to the urokinase receptor.
    Palwai NR; Zang XP; Harrison RG; Benbrook D; Pento JT
    Pharmacology; 2009; 84(5):271-5. PubMed ID: 19797936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme prodrug therapy designed to target L-methioninase to the tumor vasculature.
    Van Rite BD; Lazrak YA; Pagnon ML; Palwai NR; Neves LF; McFetridge PS; Harrison RG
    Cancer Lett; 2011 Feb; 301(2):177-84. PubMed ID: 21194833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
    Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
    Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression and large-scale production of recombinant L-methionine-alpha-deamino-gamma-mercaptomethane-lyase for novel anticancer therapy.
    Tan Y; Xu M; Tan X; Tan X; Wang X; Saikawa Y; Nagahama T; Sun X; Lenz M; Hoffman RM
    Protein Expr Purif; 1997 Mar; 9(2):233-45. PubMed ID: 9056489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
    Lin YJ; Zhen YS
    Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients.
    Tan Y; Zavala J; Xu M; Zavala J; Hoffman RM
    Anticancer Res; 1996; 16(6C):3937-42. PubMed ID: 9042316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
    Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
    Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A
    Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo.
    Guojun W; Wei G; Kedong O; Yi H; Yanfei X; Qingmei C; Yankai Z; Jie W; Hao F; Taiming L; Jingjing L; Rongyue C
    Endocr Relat Cancer; 2008 Mar; 15(1):149-59. PubMed ID: 18310283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
    Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth suppression of MCF-7 cancer cell-derived xenografts in nude mice by caveolin-1.
    Wu P; Wang X; Li F; Qi B; Zhu H; Liu S; Cui Y; Chen J
    Biochem Biophys Res Commun; 2008 Nov; 376(1):215-20. PubMed ID: 18778685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.